Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis

Wong, Zhi Yong and Teo, Chiu Yee and Wong, Yan Qi Fiona and Ng, Ka Ting and Lim, Soo Kun (2024) Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis. PLoS ONE, 19 (7). e0307981. ISSN 1932-6203, DOI https://doi.org/10.1371/journal.pone.0307981.

Full text not available from this repository.
Official URL: https://doi.org/10.1371/journal.pone.0307981

Abstract

Objective There is limited evidence on which immunosuppressive agents produce the best outcomes for adult patients with steroid-dependent or frequently relapsing nephrotic syndrome (SDNS/FRNS). This review compares the remission rate and adverse effects of various immunosuppressants used. Methods Studies of adult patients with biopsy-proven SDNS/FRNS, administered any immunosuppressive agents and reported complete remission results as one of the clinical outcomes were included. Articles were independently screened by two researchers. ROBINS-I was used for risk of bias assessment. Random-effects model was used for statistical analysis and corresponding 95% confidence intervals (CIs) were calculated. Results 574 patients across 28 studies were included in the analysis. Patients receiving rituximab have a complete remission rate of 89% (95% CI = 83% to 94%; tau 2 = 0.0070; I2 = 62%; overall p < 0.01, low certainty) and adverse event rate of 0.26, cyclosporine (CR 40%; 95% CI = 21% to 59%; tau 2 = 0.0205; I2 = 55%; overall p = 0.08, low certainty), tacrolimus (CR 84%; 95% CI = 70% to 98%; tau 2 = 0.0060; I2 = 33%; overall p = 0.21, moderate certainty), mycophenolate mofetil (CR 82%; 95% CI = 74% to 90%; tau 2 < 0.0001; I2 = 15%; overall p = 0.32, moderate certainty) and cyclophosphamide (CR 79%; 95% CI = 69% to 89%; tau 2 = 0; I2 = 0%; overall p = 0.52, moderate certainty). Conclusion Among the commonly used immunosuppressive agents, only rituximab has a statistically significant effect in achieving complete remission among patients with SDNS/FRNS and has a relatively good safety profile, but this is limited by low quality of evidence with high degree of heterogeneity causing a lack of statistical power.

Item Type: Article
Funders: UNSPECIFIED
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine
Faculty of Medicine > Anaesthesiology Department
Faculty of Medicine > Medicine Department
Depositing User: Ms. Juhaida Abd Rahim
Date Deposited: 07 Apr 2025 03:02
Last Modified: 07 Apr 2025 03:02
URI: http://eprints.um.edu.my/id/eprint/46761

Actions (login required)

View Item View Item